Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07470008 · ClinicalTrials.gov registry record

Prospective Registry of Histotripsy for Soft Tissue Tumors

A clinical trial of Soft Tissue Lesion and Soft Tissue Neoplasm, sponsored by University of California, San Francisco.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT07470008 is a study of Soft Tissue Lesion and Soft Tissue Neoplasm that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07470008, a study of Soft Tissue Lesion and Soft Tissue Neoplasm, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.

Interventions

  • OTHER Medical Record Review

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2026-01-29
Est. Completion 2031-08-08

What the Registry Record Tells You About NCT07470008

The ClinicalTrials.gov registry entry for NCT07470008 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Soft Tissue Lesion appearing as the primary indexed condition, and to 1 intervention - of which Medical Record Review is the first listed.

NCT07470008 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07470008 about?

NCT07470008 is a clinical study titled "Prospective Registry of Histotripsy for Soft Tissue Tumors". Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gat...

What is the current status of trial NCT07470008?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-01-29. Estimated completion is 2031-08-08.

What conditions does trial NCT07470008 study?

This clinical trial studies the following conditions: Soft Tissue Lesion, Soft Tissue Neoplasm, Soft Tissue Cancer.

What interventions are being tested in trial NCT07470008?

The interventions under investigation include: Medical Record Review (OTHER).

Who is sponsoring clinical trial NCT07470008?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07470008 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Soft Tissue Lesion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.